N. A. Sarsenkulova

N. A. Sarsenkulova

Auto-generated profile, based on publicly available information

N. A. Sarsenkulova

LLP «Research Institute for Biological Safety Problems», National holding «QazBioPharm

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2024 in Biosafety and Biotechnology
Verified
Journal Article
Open access
PDF file
AVA. D. Valieva
A. D. Valieva
MTM. S. Tuyskanova
M. S. Tuyskanova
MKM. K. Kenzhebaeva
M. K. Kenzhebaeva
NSN. A. Sarsenkulova
N. A. Sarsenkulova
STSh. T. Tabys
Sh. T. Tabys
Kuandyk ZhugunissovKuandyk Zhugunissov
Kuandyk Zhugunissov
The paper presents the results of determining the optimal immunising dose of inactivated vaccine against camelpox from the strain "KM - 40", obtained from the Republican Depository of especially dangerous pathogens of the Research Institute of Biological Safety Problems. The results of studies showed that intramuscular administration of inactivated vaccine against camelpox on camel rats formed antibodies to camelpox virus, the titre of which depended on the dose of the preparation. At 14 days after vaccination no antibodies were detected in the blood serum of camels immunised with the vaccine in the volumes of 2.0 and 3.0 ml, whereas in animals immunised in the volume of 5.0 ml the antibody titre was 1:2 and 1:4 in the neutralisation reaction and diffusion precipitation reaction, respectively. For use in the field, we recommend the use of 5.0 ml vaccine. If all the requirements specified in the regulations on vaccine production and control are met, this dose of the vaccine preparation ensures the formation of intense immunity against camelpox.

17 May 2026 in Biosafety and Biotechnology
Verified
Journal Article
Closed access
AAA. B. Aliyeva
A. B. Aliyeva
KBK. B. Barakbayev
K. B. Barakbayev
MAM. A. Azanbekova
M. A. Azanbekova
DMD. I. Muzarap
D. I. Muzarap
NSN. A. Sarsenkulova
N. A. Sarsenkulova
Kuandyk ZhugunissovKuandyk Zhugunissov
Kuandyk Zhugunissov
Cowpox virus, belonging to the genus Orthopoxvirus , is widely used as a model for studying orthopoxvirus infections. Despite the availability of data on the susceptibility of different animal species, its assessment under standardized experimental conditions remains limited. The aim of this study was to assess the susceptibility of laboratory animals to cowpox virus and to substantiate the selection of an optimal experimental model. The epizootic strain “COWPOX-CAM” of cowpox virus was used in this study. White mice, guinea pigs, and rabbits were employed as experimental models and infected via the intradermal route. Clinical observations were performed, and the course of the infectious process and the development of pathological changes were evaluated. In guinea pigs, the infection was mild and not associated with mortality. In white mice, the clinical manifestations of infection were mild and were not accompanied by the development of characteristic skin lesions. In rabbits, a pronounced clinical course was observed, including both local and systemic manifestations of infection. The results obtained indicate that rabbits demonstrate the highest susceptibility to cowpox virus and can be considered the most appropriate experimental model for studying the pathogenesis of infection and evaluating the efficacy of vaccines and therapeutic agents.

17 July 2025 in Biosafety and Biotechnology
Verified
Journal Article
Open access
PDF file
SKS. S. Kilibaev
S. S. Kilibaev
MKM. K. Kenzhebaeva
M. K. Kenzhebaeva
MMMuratbay Mambetaliyev
Muratbay Mambetaliyev
MAM. A. Azanbekova
M. A. Azanbekova
AVA. D. Valieva
A. D. Valieva
Kuandyk ZhugunissovKuandyk Zhugunissov
Kuandyk Zhugunissov
The preservation of strain viability and maintenance of their valuable properties are critical prerequisites for all stages of microorganism research, ranging from initial characterization to their application in the production of various biopreparations. This study investigates the revitalization of the virulent Newcastle disease virus (NDV) strain "T-53" in developing chicken embryos (DCE) and evaluates its pathogenic activity in chicks.After nine years of storage, the biological activity of the "T-53" NDV strain declined to 1.74 lg EID50/ml. Following three successive passages in DCE, the biological activity of the strain was restored to a level suitable for long-term storage. The virus-containing suspension produced was subsequently lyophilized with the addition of a protective medium in accordance with the strain's passport specifications. The quality of the lyophilized strain was evaluated using several key parameters, including appearance, absence of foreign impurities, mold, and ampoule cracks, presence of vacuum, solubility, pH value, moisture content, sterility against bacterial, fungal, and mycoplasmal contaminants, biological activity, and pathogenicity.The findings confirmed that the physicochemical and biological properties of the revitalized "T- 53" NDV strain correspond to the specifications outlined in its passport, ensuring its suitability for further use and long-term preservation.